Prescription charge statement shows Society's national policy can accommodate devolution
Andrea Robinson addresses the AGM |
The Royal Pharmaceutical Society's recent statement
on prescription charges (PJ, 26 June, p822) demonstrates that policies can be
developed on a Britain-wide basis for local implementation in each of
the home countries, the Welsh Executive's annual general meeting for
members of the Society resident in Wales heard on 7 July.
Andrea Robinson, in her report to the meeting as chairman of the executive
for 2003–04, said that the Welsh Executive had worked closely with
the Society’s Lambeth headquarters to develop a new policy on prescription
charges. It was a successful early test of the new ways of working within
the organisation.
Another major issue covered by Ms Robinson was supplementary prescribing
and the unique multidisciplinary education programme in Wales. She went
on to highlight the strength of the profession in working together and
illustrated this with reference to the Welsh Executive collaboration
with Community Pharmacy Wales and the National Public Health Service
for Wales to produce the report on the current position of community
pharmacy-based substance misuse services in Wales for the Minister for
Health and Social Regeneration.
The Welsh Executive’s annual report for 2003–04 was launched
at the AGM. Copies have been distributed to all pharmacists with registered
addresses in Wales. Further copies are available from Sarah Hickman at
the Welsh Executive office (tel 029 2041 2800; fax 029 2041 2810; e-mail wales@rpsgb.org). Copies can also be downloaded from the Welsh Executive
website
|
The
Pharmaceutical Journal